Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-008-7 | CAS number: 112-82-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 4th July to 8th August 2002
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Study conducted in compliance with agreed protocols, with no deviations from standard test guidelines and no methodological deficiencies, which do not affect the quality of the relevant results. The study report was conclusive, done to a valid guideline and the study was conducted under GLP conditions.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 003
- Report date:
- 2003
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
Test material
- Reference substance name:
- 1-bromohexadecane
- EC Number:
- 204-008-7
- EC Name:
- 1-bromohexadecane
- Cas Number:
- 112-82-3
- Molecular formula:
- C16H33Br
- IUPAC Name:
- 1-bromohexadecane
- Details on test material:
- - Substance type: White semi-solid block on arrival which melts into a clear colourless viscous liquid.
- Date received: 12th April 2002
- Storage condition of test material: Room temperature in a dark room
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: David Hall Ltd, UK and Harlan UK Ltd (used in intradermal induction sighting study).
- Age at study initiation: 8 - 12 weeks old
- Weight at study initiation: 364 to 512 g
- Housing: Individually or in pairs in a solid floor polypropylene cage.
- Diet (e.g. ad libitum): Certified Guinea Pig Diet (Code 5026) supplied by IPS Product Supplies Ltd. UK, permitted ad libitum.
- Water (e.g. ad libitum): Mains tap water ad libitum
- Acclimation period: At least 5 days.
ENVIRONMENTAL CONDITIONS
- Temperature: 17 - 23°C
- Humidity: 30-70%
- Air changes (per hr): 15 per hour.
- Photoperiod (hrs dark / hrs light): 12 hours of light 06:00 to 18:00, followed by 12 hrs of dark.
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- arachis oil
- Remarks:
- BP
- Concentration / amount:
- Concentrations were determined by a sighting test.
Intradermal induction application: 5% v/v in arachis oil BP
Epicutaneous induction application: 75% v/v in arachis oil BP
Epicutaneous challange: 50 and 25% v/v in arachis oil BP
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- arachis oil
- Remarks:
- BP
- Concentration / amount:
- Concentrations were determined by a sighting test.
Intradermal induction application: 5% v/v in arachis oil BP
Epicutaneous induction application: 75% v/v in arachis oil BP
Epicutaneous challange: 50 and 25% v/v in arachis oil BP
- No. of animals per dose:
- Total of 15 animals were used in the main test; 10 for the test and 5 for the control
- Details on study design:
- MAIN STUDY
A. INDUCTION EXPOSURE
Day 0 - Hair was removed on the shoulder region of the test animals. Three injections of volume 0.1 ml, were made in a row on each side of the mid-line:
Injection 1: Freund's Complete Adjuvant plus distilled water in the ratio 1:1
Injection 2: 5% v/v formulation of the test material
Injection 3: 5% v/v formulation of the test material in a 1:1 preparation of Freund's Complete Adjuvant plus distilled water.
Observations made at 24 and 48 hours post intradermal injection.
Day 7, epicutaneous application of 75% v/v formulation of the test material formulation at the same application site. This was covered occlusively and strapped with an elastic bandage. The animals were exposed to the test material for 48 hours.
Observations were made at 1 and 24 hours following removal of the patches.
B. CONTROL
Intradermal injections were administered in the same manner as described above, except the test material was omitted and injections were as follows:
Injection 1: Freund's Complete Adjuvant plus distilled water in the ratio 1:1
Injection 2: Vehicle
Injection 3: 50% of the vehicle in a 1:1 preparation of Freund's Complete Adjuvant plus distilled water.
Epicutaneous application was identical to as described above, except the test material was omitted.
C. CHALLENGE EXPOSURE
On day 21, epicutaneous application of the test material was applied to the flanks of each animal. 50% v/v test material in arachis oil was applied to the right flank of the animal was 25% v/v test material applied to the left flank. The sites were covered occlusively and strapped with an elastic bandage. The animals were exposed to the test material for 24 hours and diethyl ether was used to remove residual material after the 24 hour exposure time.
Observations made at 24 and 48 hours post exposure.
All erythema and oedema observations were recorded according and scored according to the scale shown in table 1 in the field "Any other information on materials and methods incl. tables". Any other reactions were also recorded. - Challenge controls:
- Challenge control performed.
- Positive control substance(s):
- not specified
Study design: in vivo (LLNA)
- Statistics:
- The senitisation potential of the test material was classified according to the scale in table 2 which can be seen in the field "Any other information on materials and method incl. tables".
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- other: Challenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25 % v/v and 50% v/v
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no other observations
- Remarks on result:
- other: Reading: other: Challenge. . Hours after challenge: 48.0. Group: test group. Dose level: 25 % v/v and 50% v/v. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: no other observations.
- Reading:
- other: Challenge
- Hours after challenge:
- 48
- Group:
- other: control
- Dose level:
- 25% v/v and 50% v/v
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- no other observations
- Remarks on result:
- other: Reading: other: Challenge. . Hours after challenge: 48.0. Group: other: control. Dose level: 25% v/v and 50% v/v. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: no other observations.
Any other information on results incl. tables
One animal was found dead on day 17. The cause of death was not determined, however it was determined that this did not result from treatment and its absence from the test did not affect the integrity of the study.
Intradermal Induction
Discrete and patch erythema were noted at the induction site of the test and control test animals.
Epicutaneous Induction
Discrete or patchy to moderate and confluent erythema and very slight oedema were noted at the topical induction sites in both test animals. No reaction was noted for the control animals. Bleeding from intradermal injections was noted in five test animals and one control animal. Small superficial scabs were also noted.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of the test the test material was determined to have a 0% sensitisation rate and is therefore classified as a non-sensitiser.
- Executive summary:
The skin sensitising potential of the test material to guinea pigs was determined by performing a maximisation test, in accordance with standardised guidelines OECD 406 and EU Method B.6. Ten test animals and five control animals were exposed to 25% v/v and 50% v/v concentrations of the test material in arachis oil BP. No signs of skin sensitisation were observed at either 24 or 48 hours post exposure.
The test material is determined to be non-sensitising and is unclassified according to Regulation 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
